medigraphic.com
ISSN 1561-3119 (Electronic)

2014, Number 4

<< Back Next >>

Rev Cubana Pediatr 2014; 86 (4)

Characterization of cystic fibrosis in the first year of life

Fuentes FG, Abreu SG, Pérez BAP, González VJA, Portuondo LR

Language: Spanish
References: 21
Page: 423-432
PDF size: 171.20 Kb.


ABSTRACT

Introduction: cystic fibrosis is a lethal multystemic and genetic disease causing early progressive pulmonary damage in typical cases.
Objective: to characterize the diagnosis of cystic fibrosis in children under one year of age.
Methods: descriptive cross-sectional study of patients diagnosed with cystic fibrosis in their first year of life, based on clinical suspicions, in the 1993-2013 period at Centro Habana hospital. To this end, data from clinical records were used.
Results: of the total number of 44 patients diagnosed with the disease in the period, 35 were classified as having typical pulmonary disease of whom 13 were diagnosed in their first year of life, 7 of 21 (33.3 %) detected in the 1993-2003 period and 6 of 14 (42.8 %) diagnosed from 2004 through 2013. When the non-typical clinical forms of disease are added, then the total amount of children diagnosed in their first year of life amounts to 16 with average age at diagnosis of 4.9 months; 11 children (68.8 %) were diagnosed before 6 months of age and males prevailed (10 for 62.5 %). Malnutrition was present in 62.5 % of the group. The typical form with pancreatic failure was observed in 75 % of under one year-old children whereas Pseudomona aeruginosa was isolated in 68.8 % of patients. Respiratory symptoms such as polypnea and hyperinsuflated thorax predominated (15 children for 93,8 %) and retraction (14 children for 87.5 %) whereas abdominal distension (11 for 68.8 %) and steatorrhea (10 for 62.5 %) were the most common digestive disturbances. Chest Xray showed some alteration in all these children.
Conclusions: the medical staff should be highly suspicious of these cases from the clinical viewpoint in order to early diagnose the typical forms of cystic fibrosis.


REFERENCES

  1. Sly P, Brennan S, Gangell C. Lung disease at diagnosis in infants with Cystic fibrosis detected by newborn screening. J Respir Crit Care Med. 2009;80:146-52.

  2. Rojo MJ. Fibrosis quística o mucoviscidosis. En: De la Torre E, Pelayo E, editores. Pediatría.Tomo III. . La Habana: Editorial Ciencias Médicas; 2007. p. 1012-54.

  3. Regamey N, Jeffery PK, Alton EWFW, Bush A, Davies JC. Airway remodelling its relationship to inflammation in Cystic fibrosis. Thorax. 2011;66:624-9.

  4. Fielbaum O. Avances en Fibrosis quística. Rev Med Clin Condes. 2011;22(2)150-9.

  5. D'Alessandro V, Rentería F, Fernández A, Martínez MI, Segal E. Comparación del estado clínico-funcional en niños con fibrosis quística detectados por pesquisa neonatal o por síntomas clínicos. Arch Argent Pediatr. Oct 2009;107(5):430-5.

  6. Razón R, Rodríguez F, Rojo MJ, González JA, Abreu G, Pérez T, et al. La fibrosis quística en Cuba. Rev Cubana Pediatr. 2009;81(Supl):85-92.

  7. Wolfenden LL, Schechter MS. Genetic and non-genetic determinants of outcomes in Cystic fibrosis. Paediatr Respir Rev. 2009;10:32-6.

  8. Slieker MG, van der Berg JMW, Kouwenberg J, Teding van Berkhout F, Heijerman HGM, van der Ent CK. Long-term effects of birth order and age at diagnosis in cystic fibrosis: a sibling cohort study. Pediatr Pulmonol. 2010;45:601-7.

  9. Robinson P. Digestive Manifestations in Cystic Fibrosis. In: Taussig LM, Landau LI, editors. Pediatric Respiratory Medicine. 2nd ed. Philadelphia: Mosby Elsevier; 2008. p. 889.

  10. Dodge JA, Lewis PA, Stanton M, Wilsher J. Cystic fibrosis mortality and survival in the UK: 1947-2003. Eur Respir J. 2007;29:522-6.

  11. Guzmán K, del Campo E, Nápoles N, Toledano G, Coello D. Principales características clínico epidemiológicas de pacientes con fibrosis quística en la provincia de Santiago de Cuba. Medisan. 2011;15(2):152.

  12. Mott LS, Park J, Murray CP, Gangell CL, de Klerk NH, Robinson PJ, et al. Progression of early structural lung disease in young children with cystic fibrosis assesedusing CT. Thorax [serie en Internet]. 2011 [citado 13 de abril de 2012]. Disponible en: http://thorax.bmj.com/content/early/2011/12/26/thoraxjnl-2011- 200912.full.html

  13. Wainwright CE, Vidmar S, Armstrong DS, Byrnes CA, Carlin JB, Cheney J, et al. Effect of bronchioalveolar lavage directed therapy on Pseudomonas aeruginosa infection and structural lung injury in children with Cystic fibrosis: a randomized trial. JAMA. 2011;306(2):163-71.

  14. Egan M. Fibrosis Quística. En: Kliegman RM, Stanton BF, editores. Nelson. Tratado de Pediatría. 19th ed. Barcelona: Saunders Elsevier; 2013. p. 1540-56.

  15. Sly PD, Gangell CL, Chen L, Ware RS, Ranganathan S, Mott LS, et al. Risk factors for bronchiectasis in children with Cystic fibrosis. NEJM. 2013;368(21):1963-70. Revista Cubana de Pediatría. 2014;86(4):423-432 http://scielo.sld.cu 432

  16. Tiddens HAWM, Rosenfeld M. Respiratory manifestations in Cystic fibrosis. En: Taussig LM, Landau LI, editores. Pediatric Respiratory Medicine. 2nd ed. Philadelphia: Mosby Elsevier; 2008. p. 871-87.

  17. Simmonds NJ, D'Souza L, Roughton M, Alton EWFW, Davies JC, Hodson ME. Cystic fibrosis and survival to 40 years: a study of Cystic fibrosis transmembrane conductance regulator function. Eur Respir J. 2011;37:1076-82.

  18. Muniz AE, Bartle S, Foster R. Edema, anemia and acrodermatitis enteropathica: an uncommon initial presentation of Cystic fibrosis. Pediatr Emerg Care. 2004;20(2):112-4.

  19. Levy H, Kalish LA, Cannon CL, Garcia KC, Gerard C, Goldman D, et al. Predictors of mucoid pseudomonas colonization in Cystic Fibrosis patients. Pediatr Pulmonol. 2008;43:463-71.

  20. Callagham M, Mc Clean S. Bacterial host interactions in Cystic Fibrosis. Curr Opinion Microbiol. 2012;15:71-7.

  21. Stenbit AE, Flume PA. Pulmonary exacerbations in Cystic fibrosis. Curr Opinion Microbiol. 2011;17:442-7.




2020     |     www.medigraphic.com